about
Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicinePolymorphisms in genes involved in drug detoxification and clinical outcomes of anthracycline-based neoadjuvant chemotherapy in Chinese Han breast cancer patients.Defining and managing risk in asthma.Restoration of paclitaxel resistance by CDK1 intervention in drug-resistant ovarian cancer.ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.Neural correlates of individual differences in circadian behaviour.
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Current progress in pharmacogenetics.
@ast
Current progress in pharmacogenetics.
@en
Current progress in pharmacogenetics.
@nl
type
label
Current progress in pharmacogenetics.
@ast
Current progress in pharmacogenetics.
@en
Current progress in pharmacogenetics.
@nl
prefLabel
Current progress in pharmacogenetics.
@ast
Current progress in pharmacogenetics.
@en
Current progress in pharmacogenetics.
@nl
P2860
P1476
Current progress in pharmacogenetics
@en
P2093
John D Blakey
P2860
P304
P356
10.1111/J.1365-2125.2011.03912.X
P407
P577
2011-06-01T00:00:00Z